Clinical researcher using the MACSQuant Tyto Cartridge for closed and sterile cell sorting.
Clinical researcher using the MACSQuant Tyto Cartridge for closed and sterile cell sorting.
Logo

Clinical cell sorting applications

Facilitating GMP-compliant cell sorting in cell therapy

Cell manufacturing demands the highest standards of safety, precision, and reliability. The MACSQuant® Tyto® Family enables gentle cell sorting that preserves cell functionality, delivering high-quality cell products in a cartridge-based system.

In the closed cartridge and without fluidics, cells are kept sterile at all times and are never in contact with the instrument. Our MACS® GMP Tyto Consumables and MACSQuantify™ Tyto Software enable GMP compliance while streamlining your transition to regulated environments.

Since its launch in 2016, the MACSQuant Tyto Cell Sorter has been supporting numerous clinical trials worldwide.

Note: The MACSQuant Tyto Family of cell sorters and related accessory products are not sold as medical devices.

Successful workflows for GMP-compliant cell manufacturing and analytics

Flow cytometry–based assays are critical in cell manufacturing workflows. With our MACS GMP Tyto Consumables, the MACSQuant Tyto Cell Sorter enables seamless transition to regulated environments, offering a safe and gentle solution for cell therapy workflows.

Choose your cells of interest

Sorting rare antigen-specific T cells in cell manufacturing workflows

Antigen-specific T cell therapies offer immense potential for treating cancer, infectious diseases, and autoimmune disorders. Due to their unique specificity, antigen-specific T cells are diverse and rare, representing only 0.01–0.1% of the T cell pool, and therefore exceptionally challenging to detect and isolate. The MACSQuant Tyto Family enables gentle, high-purity isolation of these rare T cells, paving the way for advanced research and therapeutic breakthroughs.

Flow cytometry analysis showing enrichment of antigen-specific T cells after cell sorting on the MACSQuanrt Tyto Cell Sorter using MHC MACSimers.
Gentle and sterile cell sorting of antigen-specific T cells to high purity using the MACSQuant Tyto Cell Sorter.

Precision and purity with the MACSQuant Tyto Family and MHC MACSimers

Explore our data on the isolation of rare antigen-specific T cells with high purity, using the gentle and sterile cell sorting of the MACSQuant Tyto Cell Sorter in combination with our MHC multimer technology.

High-purity sorting: Our advanced microfluidics technology delivers precise, multiparameter sorting, delivering highly pure cell populations.

Workflow overview for the isolation of antigen-specific CD8 T cells for the treatment of melanoma.

Enabling safe, scalable T cell therapies: Insights from a clinical trial with metastatic melanoma patients

In this phase II clinical trial, the MACSQuant Tyto Cell Sorter was used to isolate antigen-specific CD8⁺ T cells from patient-derived peripheral blood mononuclear cells (PBMCs), following CD25⁺ regulatory T cell depletion with the CliniMACS® Plus Instrument.

Reliability: The MACSQuant Tyto Cell Sorter consistently delivered high purity and yield, providing high-quality cell products.

Effective post-sort cell expansion: The gentle microchip technology preserved cell viability and functionality in a closed, sterile environment, promoting effective post-sort cell expansion in vitro.

Get more insights into this exciting trial in this scientific poster:

Icon showing two documents connected with an arrow
Publication/study

The MACSQuant Tyto Cell Sorter is featured in the first-in-human clinical trial for multi-target adoptive cell therapy in patients with advanced metastatic cancer

Tsimberidou, A.M. et al. (2023) Cancer Immunol Res. 11 (7): 925–945.

In this pioneering clinical trial, the MACSQuant Tyto Cell Sorter was used to isolate CD8⁺ T cells specific for up to four predefined peptide-HLA cancer targets. These endogenous cells were primed, expanded, and reinfused following lymphodepletion.

Target-specific T cells reached up to 78.7% of CD8⁺ cells in the patient's blood, persisted for over a year, were detected in post-treatment tumor tissue, and were associated with signs of disease stabilization in some patients. These results underscore the critical role of gentle, safe, and precise cell sorting for cell therapy workflows.

Read the whole article here

" We use the MACSQuant Tyto Cell Sorter for the GMP manufacturing of patients' antigen-specific T cells for Immatics' clinical trials, and have successfully manufactured more than 60 patient products to date. The device is easy to use even in this rigorous environment, and I have been very impressed with its performance, especially utilizing the closed and sterile cartridge system to provide a safe environment for the sorted cells. Moreover, the gentle, microchip-based sorting mechanism preserves high viability amongst patients' precious cells."

Ali Mohamed, PhD, Vice President CMC
Immatics, Houston, USA

Sterile and safe sorting of tumor-infiltrating lymphocytes

Tumor-infiltrating lymphocytes (TILs) are tumor-reactive immune cells that naturally migrate into the tumor microenvironment. TIL therapy has shown promising results, especially in solid tumors like melanoma. Our GMP-compliant sorting workflow streamlines clinical-grade TIL manufacturing.

Webinar

Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

Watch the webinar to learn how the MACSQuant Tyto Cell Sorter is being used to achieve sterile, high-purity sorting of tumor-reactive TILs, a critical step in the development of adoptive cell therapy for the treatment of refractory metastatic melanoma.

Gentle cell sorting in stem cell–based regenerative medicine workflows

Stem cells, like induced pluripotent stem cells (iPSCs) hold immense promise in regenerative medicine due to their unique ability to self-renew and differentiate into diverse specialized cell types. The MACSQuant Tyto Family provides gentle sorting in a closed cartridge that protects and preserves the delicate nature of stem cells.

Workflow showing the generation and isolation of iPSC-derive dopaminergic progenitors to treat Parkinson’s disease
Clinical trial workflow for iPSC-derived dopaminergic cell therapy in Parkinson's disease

A pioneering clinical trial to treat Parkinson’s disease is using the MACSQuant Tyto Cell Sorter

In a groundbreaking clinical trial, now published in Nature (Sawamoto, N. et al., see below), Jun Takahashi’s team used iPSC-derived dopaminergic progenitors from HLA-matched healthy donors to treat Parkinson's disease. During the preclinical development, the team switched from a conventional droplet sorter to the MACSQuant Tyto Cell Sorter, and the impact was significant:

Improved cell viability: Gentle, sterile sorting significantly increased post-sort survival rates, resulting in higher yields of viable dopaminergic progenitors with preserved functionality.

Reduced sorting time: The MACSQuant Tyto Cell Sorter streamlined the sorting process, reducing the estimated time for cell production by one-third.

Icon showing two documents connected with an arrow
Publication/study

The MACSQuant Tyto Cell Sorter is featured in a pioneering clinical trial for Parkinson’s disease.

Sawamoto, N. et al. (2025) Nature 641, 971–977.

In this groundbreaking clinical trial published in Nature, Jun Takahashi’s team at CiRA (Kyoto, Japan) chose the MACSQuant Tyto Cell Sorter to gently isolate dopaminergic progenitor cells, preserving cell functionality while increasing workflow efficiency.

Read the whole article here

High-purity sorting of regulatory T cells

Regulatory T cells (Tregs) comprise only 1–4% of circulating peripheral blood mononuclear cells (PBMCs). Essential in preventing autoimmunity, their immunosuppressive role makes them a powerful tool for cell and gene therapy. However, their low abundance and phenotypic overlap with other T cell subsets present significant challenges for their application. The MACSQuant Tyto Family offers a gentle solution.

Infographic of the regulatory T cell enrichment using the CliniMACS Prodigy and the MACSQuant Tyto Cell Sorter
Overview of the Treg isolation workflow using the CliniMACS Prodigy and the MACSQuant Tyto Cell Sorter.

Accelerate your regulatory T cell research with a closed and sterile system

Regulatory T cells were isolated from leukapheresis products through a workflow combining automated pre-enrichment on the CliniMACS Prodigy® and high-purity sorting on the MACSQuant Tyto Cell Sorter. A sequential cell sorting approach enabled enrichment from 38% to a final purity of 98%.

Read the whole study here:

Isolation of human Tregs with the CliniMACS Prodigy and the MACSQuant Tyto Cell Sorter (application note)